Padilla, Carmelita L.
HRN: 28-98-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
CEFTRIAXONE 1G (VIAL)
05/12/2026
05/18/2026
IV
2G
OD
CAP MR
Checking Initial Appropriateness
05/12/2026
MUPIROCIN 2%, 15G (TUBE)
05/12/2026
05/18/2026
TOPICAL
.
OD
SKIN INFECTION
Checking Initial Appropriateness